A Florida doctor has passed on several weeks of getting a COVID-19 antibody, even though it’s not yet sure whether his demise Monday was identified with the shot he got on Dec. 18.
Dr. Gregory Michael, 56, an OB-GYN at Mount Sinai Medical Center in Miami Beach, passed on after suffering a hemorrhagic stroke evidently coming about because of an absence of platelets.
Miami medical examiners are researching his death, the Florida Department of Health said in a statement.
Jason Mahon (communications director) said in an email, “The CDC and FDA are responsible for reviewing COVID-19 vaccine safety data and presenting that information for federal recommendations on vaccine administration”. “The state will continue to provide all available information to the CDC as they lead this investigation.”
Heidi Neckelmann (Michael’s wife) said in a Facebook post that he sought emergency care three days after the shot because he had dots on his skin that indicated internal bleeding.
The condition she said prompted his stroke, called thrombocytopenia, results from a lower-than-normal number of platelets, which help the blood clot.
In extremely few cases, the measles, mumps, and rubella immunization has been connected to thrombocytopenia in small kids, as indicated by a 2003 study. The condition can likewise be brought about by disease, anemia, heavy drinking, viruses, some genetic conditions, toxic chemicals, and medications, for example, diuretics and the once in a while utilized anti-infection chloramphenicol.
Pfizer, which alongside its partner BioNTech made the antibody the man got, said in a statement it knows about the demise.
“We are actively investigating this case, but we don’t believe at this time that there is any direct connection to the vaccine,” the statement said.
There is no sign – either from enormous clinical trials or among individuals who have gotten the antibody since the government authority approved its utilization a month ago – that it very well may be associated with thrombocytopenia, the organization said.
Coronavirus antibody producers are needed by the government authority to monitor medical conditions that happen close to inoculation and research whether they will probably be associated with a shot.